ProMIS Neurosciences Book Value Per Share Growth & History (PMN)
ProMIS Neurosciences's book value per share was -$0.58 for fiscal 2025.
View full ProMIS Neurosciences company overviewProMIS Neurosciences annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | -$0.58 | -$13.20 | — |
| 2024 | 2024-12-31 | $12.61 | -$12,408.77 | −99.90% |
| 2023 | 2023-12-31 | $12,421.38 | $22,239.89 | — |
| 2022 | 2022-12-31 | -$9,818.51 | -$58,981.48 | — |
| 2021 | 2021-12-31 | $49,162.98 | — | — |
ProMIS Neurosciences quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.51 | $736.98 | — |
| Q1 2026 | 2026-03-31 | $6.77 | -$18,102.68 | −99.96% |
| Q4 2025 | 2025-12-31 | -$0.58 | -$13.20 | — |
| Q3 2025 | 2025-09-30 | $10,670.84 | -$3,235.17 | −23.26% |
| Q2 2025 | 2025-06-30 | -$731.47 | $6,774.28 | — |
| Q1 2025 | 2025-03-31 | $18,109.45 | $17,855.31 | +7025.91% |
| Q4 2024 | 2024-12-31 | $12.61 | -$12,408.77 | −99.90% |
| Q3 2024 | 2024-09-30 | $13,906.01 | -$8,883.45 | −38.98% |
| Q2 2024 | 2024-06-30 | -$7,505.75 | $54,622.77 | — |
| Q1 2024 | 2024-03-31 | $254.14 | $45,268.43 | — |
| Q4 2023 | 2023-12-31 | $12,421.38 | $22,239.89 | — |
| Q3 2023 | 2023-09-30 | $22,789.46 | $16,450.77 | +259.53% |
| Q2 2023 | 2023-06-30 | -$62,128.52 | -$120,410.62 | — |
| Q1 2023 | 2023-03-31 | -$45,014.30 | — | — |
| Q4 2022 | 2022-12-31 | -$9,818.51 | -$58,981.48 | — |
| Q3 2022 | 2022-09-30 | $6,338.69 | — | — |
| Q2 2022 | 2022-06-30 | $58,282.10 | — | — |
| Q4 2021 | 2021-12-31 | $49,162.98 | — | — |
ProMIS Neurosciences book value per share trends
Between the periods ended 2021-12-31 and 2025-12-31, ProMIS Neurosciences's book value per share decreased from $49,162.98 to -$0.58, a change of -$49,163.56. The latest reported quarter, Q2 2026, shows $5.51.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ProMIS Neurosciences source filings ↗